(Q42451919)

reason for preferred rank

31 October 2017

title

Improvement of Endothelial Dysfunction by Selective Estrogen Receptor-α Stimulation in Ovariectomized SHR (English)

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

25 March 2024

Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14581292

25 March 2024

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

25 March 2024

9

Johann Bauersachs

1 reference

31 October 2017

Julian Widder

1

1 reference

31 October 2017

Theo Pelzer

2

1 reference

31 October 2017

Christine von Poser-Klein

3

1 reference

31 October 2017

Kai Hu

4

1 reference

31 October 2017

Virginija Jazbutyte

5

1 reference

31 October 2017

Karl-Heinrich Fritzemeier

6

1 reference

31 October 2017

Christa Hegele-Hartung

7

1 reference

31 October 2017

Ludwig Neyses

8

1 reference

31 October 2017

language of work or name

English

0 references

publication date

27 October 2003

1 reference

31 October 2017

1 reference

31 October 2017

volume

42

1 reference

31 October 2017

issue

5

1 reference

31 October 2017

page(s)

991-996

1 reference

The protective effects of estrogen on the cardiovascular system

31 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Estrogen increases endothelial nitric oxide by a receptor-mediated system

25 March 2024

2

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells

25 March 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

American Journal of Physiology

25 March 2024

5

273

L119

1997

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Short-term administration of estrogen and vascular responce of atherosclerotic coronary arteries

25 March 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

25 March 2024

12

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

25 March 2024

15

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

25 March 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

25 March 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Design and methods of the Raloxifene Use for The Heart (RUTH) study

25 March 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury

25 March 2024

22

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice

25 March 2024

24

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta

25 March 2024

25

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression

25 March 2024

29

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population

25 March 2024

30

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats

25 March 2024

33

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

25 March 2024

35

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Hormone replacement therapy, heart disease, and other considerations

25 March 2024

37

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats

25 March 2024

39

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta.

25 March 2024

44

1 reference

https://api.crossref.org/works/10.1161/01.HYP.0000098661.37637.89

25 March 2024

Identifiers

1 reference

31 October 2017

1 reference